ロード中...
Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis
PURPOSE: The best adjuvant treatment in high-risk endometrial cancer remains unclear. Although adjuvant chemotherapy seems to improve overall survival (OS) in locally advanced disease, the role of adding radiotherapy is not certain. We evaluated the outcomes of patients with high-risk endometrial ca...
保存先:
| 出版年: | J Glob Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6223436/ https://ncbi.nlm.nih.gov/pubmed/30241227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.17.00146 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|